Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Medtronic plc
  6. Summary
    MDT   IE00BTN1Y115

MEDTRONIC PLC

(MDT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
130.04(c) 130.58(c) 131.65(c) 130.92(c) 129.7(c) Last
4 703 232 3 333 653 3 303 943 3 049 513 6 621 684 Volume
-0.84% +0.42% +0.82% -0.55% -0.93% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 32 995 M - -
Net income 2022 5 704 M - -
Net Debt 2022 20 694 M - -
P/E ratio 2022 32,7x
Yield 2022 1,85%
Sales 2023 34 807 M - -
Net income 2023 6 545 M - -
Net Debt 2023 18 483 M - -
P/E ratio 2023 26,6x
Yield 2023 1,97%
Capitalization 175 B 175 B -
EV / Sales 2022 5,92x
EV / Sales 2023 5,55x
Nbr of Employees 90 000
Free-Float 99,7%
More Financials
Company
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.9%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - vascular diseases and cardiac surgery (18.4%): coronary stents, endoprostheses for aortal pathologies, distal protection... 
Read more
Sector
Medical Equipment, Supplies & Distribution
Calendar
09/17 | 12:35pmPresentation
More about the company
Ratings of Medtronic plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about MEDTRONIC PLC
09/14Medtronic to Seek Acquisitions
CI
09/14MEDTRONIC : Says US Patent Office Rejects Axonics' Challenge to Bladder Device P..
MT
09/13MEDTRONIC : U.S. Patent and Trademark Office Rejects Axonics' Challenge to Medtr..
PR
09/13MEDTRONIC : Collaboration with Mpirik to Address Disparities in Care Associated ..
PR
09/13Medtronic Collaboration with Mpirik to Address Disparities in Care Associated..
CI
09/10MEDTRONIC PLC : Regulation FD Disclosure (form 8-K)
AQ
09/09MEDTRONIC : 2021 Virtual Wells Fargo Healthcare Conference Presentation
PU
09/07MEDTRONIC : Executives to Speak at Upcoming Investor Conferences
AQ
09/07MEDTRONIC : Announces NAVABLATE Study Results Released in Late-Breaking Podium P..
PR
09/07Medtronic plc Announces NAVABLATE Study Results Released in Late-Breaking Pod..
CI
09/02MEDTRONIC : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
09/02Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2..
CI
09/01MEDTRONIC : BetterInvesting™ Magazine Selects Medtronic as "Growth" Stock ..
PR
08/30MEDTRONIC : Real-World Data Demonstrate Significant Reduction in Complications a..
AQ
08/27MEDTRONIC : Says Micra Leadless Pacemaker Significantly Reduced Complications, R..
MT
More news
News in other languages on MEDTRONIC PLC
09/14Medtronic déclare que l'Office américain des brevets rejette la contestation ..
09/10TAGESVORSCHAU : Termine am 10. September 2021
09/02++ Analysen des Tages von Dow Jones Newswires (2.9.2021) +++
09/01WOCHENVORSCHAU : Termine bis 14. September 2021
08/30MILLIARDEN-ÜBERNAHME IN MEDIZINTECHN : Baxter will Hill-Rom
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Analysis
Automakers, medical device firms ask Biden for U.S. chip factory subsidies
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 29
Last Close Price 129,70 $
Average target price 145,92 $
Spread / Average Target 12,5%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC10.72%174 552
ABBOTT LABORATORIES15.80%224 776
BECTON, DICKINSON AND COMPANY4.69%75 229
HOYA CORPORATION30.10%62 323
ALIGN TECHNOLOGY, INC.34.62%56 839
SARTORIUS STEDIM BIOTECH79.60%56 591